<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0074">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Xiong</surname>
    <given-names>R.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sun</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ding</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhao</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shang</surname>
    <given-names>W.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Jiang</surname>
    <given-names>X.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2</article-title>. 
  <source>
   <italic>bioRxiv</italic>
  </source>. 
  <pub-id pub-id-type="doi">10.1101/2020.03.11.983056</pub-id>
 </mixed-citation>
</ref>
